Dissecting Perioperative Immunotherapy Approaches in Early-Stage NSCLC

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss evolving perioperative immunotherapy approaches in early-stage non–small cell lung cancer.

EP. 1: How Immunotherapy Is Affecting Perioperative Treatment Decisions in Early-Stage NSCLC

July 17th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss how immunotherapy is affecting perioperative treatment in early-stage non–small cell lung cancer.

EP. 2: Perioperative Nivolumab in Resectable NSCLC: Updated Data From CheckMate-77T

July 17th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss updated data from CheckMate-77T of perioperative nivolumab in resectable NSCLC.

EP. 3: Surgical Outcomes From CheckMate-77T With Perioperative Nivolumab in Resectable NSCLC

July 24th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss surgical outcomes from CheckMate-77T for perioperative nivolumab in resectable NSCLC.

EP. 4: Updated Findings From CheckMate-816 for Neoadjuvant Nivolumab Plus Chemo in Resectable NSCLC

July 24th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss updated findings for neoadjuvant nivolumab plus chemotherapy in resectable NSCLC.

EP. 5: Factors Influencing Adjuvant Treatment Decisions in Early-Stage NSCLC

August 7th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss factors that affect adjuvant treatment decisions in early non–small cell lung cancer.

EP. 6: How Immunotherapy Could Continue to Affect Early-Stage NSCLC Management

August 7th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss how immunotherapy could continue to reshape early NSCLC management.

EP. 7: Unmet Needs Research Aims to Address in Early-Stage NSCLC

August 14th 2025

Wade T. Iams, MD, and Jessica Donington, MD, MSCR, discuss ongoing research in early-stage non–small cell lung cancer.